The former head of Johnson & Johnson’s worldwide medtech business, Ashley McEvoy, has signed up to lead the insulin ...

The CEO of Novo Holdings has warned that his $160 billion fund will slow down investment activity until the dust settles ...

Tonix has no tonic for cocaine intoxication, with the biopharma terminating a midstage trial for the condition amid poor ...

Boehringer Ingelheim unveiled new data from its top oncology prospect zongertinib, further backing the drug’s prowess in ...

Spruce Biosciences has swept away 55% of its employees. The biotech took the action days after inking a deal for a former ...

Transplanting bacteria from the feces of healthy people into the guts of mice and patients with fibromyalgia successfully ...

Pfizer has linked its PD-1 inhibitor to a 32% reduction in the risk of disease-related events in a phase 3 bladder cancer ...

Emerging pulsed field ablation systems had their moments in the spotlight at the annual meeting of the Heart Rhythm Society ...